Literature DB >> 15780501

Homocysteinemia is a risk factor for aortic dissection.

Hisato Takagi1, Takuya Umemoto.   

Abstract

There are significant associations between moderate increases in serum homocysteine and three cardiovascular diseases: ischemic heart disease, deep vein thrombosis and pulmonary embolism, and stroke. An association between the presence of abdominal aortic aneurysm and elevated homocysteine plasma levels has been indicated. Although chronic systemic hypertension is the most common factor predisposing the aorta to dissection, homocysteinemia has never been known as the risk for aortic dissection except for that with Marfan syndrome. Homocysteinemia is suggested to be the risk for aortic dissection in Marfan syndrome and spontaneous cervical artery dissection. Reduced fibrillin-1 deposition into the extracellular matrix is found not only in Marfan syndrome but also in isolated ascending aortic aneurysm and dissection. The reduced matrix deposition produces a mild form of weakness of elastic tissue, which predisposes to ascending aortic aneurysm and dissection in patients who do not have the Marfan syndrome. The defect in fibrillin-1 leads to: (1) formation of elastin that is abnormally aggregated and more easily degraded by matrix metalloproteinases than is normal elastin; (2) upregulation of the synthesis of matrix metalloproteinases; (3) progressive destruction of connective tissue by these enzymes; (4) development of thoracic aortic aneurysms. Homocysteine causes premature breakdown in the arterial elastic fibers by activation of the elastolytic activities. Irreversible homocysteinylation of long-lived proteins should lead to cumulative damage and progressive clinical manifestations, and fibrillin-1 is seen as the paradigm of extracellular connective tissue proteins that are specially susceptible to homocysteine (and presumably homocysteine thiolactone) attack. The authors hereupon propose a novel hypothesis that homocysteine plays an important role in development of aortic dissection and that homocysteinemia is one of the risk factors for aortic dissection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780501     DOI: 10.1016/j.mehy.2004.10.017

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  10 in total

1.  Homocysteine modifies structural and functional properties of fibronectin and interferes with the fibronectin-fibrillin-1 interaction.

Authors:  Dirk Hubmacher; Laetitia Sabatier; Douglas S Annis; Deane F Mosher; Dieter P Reinhardt
Journal:  Biochemistry       Date:  2011-05-19       Impact factor: 3.162

2.  Moderately Elevated Homocysteine Does Not Contribute to Thoracic Aortic Aneurysm in Mice.

Authors:  Jasmin Roohi; Benjamin Kang; David Bernard; Djahida Bedja; Harry C Dietz; Lawrence C Brody
Journal:  J Nutr       Date:  2017-05-24       Impact factor: 4.798

Review 3.  Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets.

Authors:  Yi Fu; Xian Wang; Wei Kong
Journal:  Br J Pharmacol       Date:  2017-09-22       Impact factor: 8.739

4.  Three-vessel spontaneous coronary artery dissection in a patient with hyperhomocysteinemia.

Authors:  Christos S Katsouras; Michail I Papafaklis; Lampros Lakkas; Aidonis Rammos; Lampros K Michalis
Journal:  J Cardiol Cases       Date:  2021-09-21

Review 5.  [Imaging of aortic disease].

Authors:  P Reimer; R Vosshenrich; P Landwehr; M Storck
Journal:  Radiologe       Date:  2007-05       Impact factor: 0.635

6.  Hyperhomocysteinemia during aortic aneurysm, a plausible role of epigenetics.

Authors:  Nithya Narayanan; Neetu Tyagi; Amy Shah; Sebastian Pagni; Suresh C Tyagi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-03-08

7.  Epigenetic regulation of aortic remodeling in hyperhomocysteinemia.

Authors:  Nithya Narayanan; Sathnur Basappa Pushpakumar; Srikanth Givvimani; Sourav Kundu; Naira Metreveli; Dexter James; Adrienne P Bratcher; Suresh C Tyagi
Journal:  FASEB J       Date:  2014-04-16       Impact factor: 5.191

8.  Plasma Amino Acid Profile in Patients with Aortic Dissection.

Authors:  Linlin Wang; Sha Liu; Wengang Yang; Haitao Yu; Li Zhang; Ping Ma; Peng Wu; Xue Li; Kenka Cho; Song Xue; Baohong Jiang
Journal:  Sci Rep       Date:  2017-01-10       Impact factor: 4.379

9.  Plasma and Aorta Biochemistry and MMPs Activities in Female Rabbit Fed Methionine Enriched Diet and Their Offspring.

Authors:  Khira Othmani Mecif; Souhila Aouichat Bouguerra; Yasmina Benazzoug
Journal:  J Nutr Metab       Date:  2017-01-04

10.  Hyperhomocysteinia is a risk factor for retinal venous occlusion: a case control study.

Authors:  Fahad Al Wadani; Rajiv Khandekar; Gigani Salim; Mohammed Al Ali; Salman Ramzi
Journal:  Indian J Ophthalmol       Date:  2014-03       Impact factor: 1.848

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.